| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF133 ZNF311 ZNF777 ZNF266 HDAC5 HELT ZNF329 ZNF189 ZNF880 POU3F4 POU4F2 ZNF362 PPARA ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 TFAP2B ZNF774 ZNF786 HOXA4 ZNF250 ZNF610 ZNF776 ZNF320 USF3 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 SIX2 ZNF574 ZNF697 ZNF646 FOXC2 | 3.18e-15 | 1459 | 157 | 44 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF133 ZNF311 ZNF777 ZNF266 HDAC5 GPER1 HELT ZNF329 ZNF189 ZNF880 POU3F4 POU4F2 PPARA ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 TFAP2B ZNF774 ZNF786 HOXA4 ZNF250 ZNF610 ZNF776 ZNF320 USF3 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 SIX2 ZNF574 ZNF697 ZNF646 FOXC2 | 5.10e-15 | 1412 | 157 | 43 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF311 HDAC5 HELT ZNF189 ZNF880 POU3F4 POU4F2 ZNF362 PPARA ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 TFAP2B ZNF774 ZNF786 HOXA4 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 SIX2 ZNF574 ZNF697 ZNF646 FOXC2 | 5.18e-14 | 1244 | 157 | 39 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF311 HDAC5 HELT ZNF189 ZNF880 POU3F4 POU4F2 ZNF362 PPARA ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 TFAP2B ZNF774 ZNF786 HOXA4 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 SIX2 ZNF574 ZNF697 ZNF646 FOXC2 | 1.03e-13 | 1271 | 157 | 39 | GO:0000987 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 2.90e-05 | 23 | 157 | 4 | GO:0030021 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.23e-04 | 188 | 157 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 1.29e-04 | 13 | 157 | 3 | GO:0140410 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | POU4F2 PPARA ZNF226 ZNF227 ZNF229 ZNF467 TFAP2B ZNF786 USF3 ZNF814 ZNF770 SIX2 ZNF574 FOXC2 | 1.40e-04 | 560 | 157 | 14 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | POU4F2 PPARA ZNF226 ZNF227 ZNF229 ZNF467 TFAP2B ZNF786 USF3 ZNF814 ZNF770 SIX2 ZNF574 FOXC2 | 1.57e-04 | 566 | 157 | 14 | GO:0001216 |
| GeneOntologyMolecularFunction | zinc ion transmembrane transporter activity | 8.55e-04 | 24 | 157 | 3 | GO:0005385 | |
| Domain | - | ZNF133 ZNF311 ZNF777 ZNF775 ZNF266 ZNF329 ZNF189 ZNF880 ZNF362 ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 ZNF574 ZNF697 ZNF646 | 3.87e-18 | 679 | 158 | 35 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF133 ZNF311 ZNF777 ZNF775 ZNF266 ZNF329 ZNF189 ZNF880 ZNF362 ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 ZNF574 ZNF697 ZNF646 | 7.34e-18 | 693 | 158 | 35 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF133 ZNF311 ZNF777 ZNF775 ZNF266 ZNF329 ZNF189 ZNF880 ZNF362 ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 ZNF574 ZNF697 ZNF646 | 7.68e-18 | 694 | 158 | 35 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF133 ZNF311 ZNF777 ZNF775 ZNF266 ZNF329 ZNF189 ZNF880 ZNF362 ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 ZNF574 ZNF697 ZNF646 | 2.34e-16 | 775 | 158 | 35 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF133 ZNF311 ZNF777 ZNF775 ZNF266 ZNF329 ZNF189 ZNF880 ZNF362 ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 ZNF574 ZNF697 ZNF646 | 2.53e-16 | 777 | 158 | 35 | PS00028 |
| Domain | Znf_C2H2-like | ZNF133 ZNF311 ZNF777 ZNF775 ZNF266 ZNF329 ZNF189 ZNF880 ZNF362 ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 ZNF574 ZNF697 ZNF646 | 5.30e-16 | 796 | 158 | 35 | IPR015880 |
| Domain | Znf_C2H2 | ZNF133 ZNF311 ZNF777 ZNF775 ZNF266 ZNF329 ZNF189 ZNF880 ZNF362 ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 ZNF574 ZNF697 ZNF646 | 7.46e-16 | 805 | 158 | 35 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF133 ZNF311 ZNF777 ZNF775 ZNF266 ZNF329 ZNF189 ZNF880 ZNF362 ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 ZNF574 ZNF697 ZNF646 | 8.36e-16 | 808 | 158 | 35 | SM00355 |
| Domain | KRAB | ZNF133 ZNF311 ZNF777 ZNF266 ZNF189 ZNF880 ZNF226 ZNF227 ZNF229 ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF814 ZNF534 ZNF420 ZFP92 ZNF160 ZNF471 | 3.18e-12 | 358 | 158 | 21 | PS50805 |
| Domain | zf-C2H2_6 | ZNF133 ZNF311 ZNF266 ZNF329 ZNF880 ZNF227 ZNF229 ZNF467 ZNF250 ZNF320 ZNF497 ZNF814 ZNF770 ZNF420 ZFP92 ZNF160 ZSCAN23 ZNF574 ZNF646 | 2.16e-11 | 314 | 158 | 19 | PF13912 |
| Domain | KRAB | ZNF133 ZNF311 ZNF777 ZNF266 ZNF189 ZNF880 ZNF226 ZNF227 ZNF229 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF814 ZNF534 ZNF420 ZFP92 ZNF160 ZNF471 | 4.52e-11 | 369 | 158 | 20 | SM00349 |
| Domain | KRAB | ZNF133 ZNF311 ZNF777 ZNF266 ZNF189 ZNF880 ZNF226 ZNF227 ZNF229 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF814 ZNF534 ZNF420 ZFP92 ZNF160 ZNF471 | 4.74e-11 | 370 | 158 | 20 | IPR001909 |
| Domain | KRAB | ZNF133 ZNF311 ZNF777 ZNF189 ZNF880 ZNF226 ZNF227 ZNF229 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF814 ZNF534 ZNF420 ZFP92 ZNF160 ZNF471 | 2.04e-10 | 358 | 158 | 19 | PF01352 |
| Domain | PID | 6.81e-06 | 32 | 158 | 5 | PS01179 | |
| Domain | LRR | 8.37e-06 | 201 | 158 | 10 | PS51450 | |
| Domain | LRR_8 | 1.53e-05 | 171 | 158 | 9 | PF13855 | |
| Domain | LRRNT | 1.97e-05 | 98 | 158 | 7 | IPR000372 | |
| Domain | LRRNT | 1.97e-05 | 98 | 158 | 7 | SM00013 | |
| Domain | Leu-rich_rpt | MXRA5 RTN4R LRRC72 CHADL DCN NOD2 TSKU LRRC3 AMIGO3 LRRC53 PHLPP2 | 2.01e-05 | 271 | 158 | 11 | IPR001611 |
| Domain | LRR_TYP | 2.01e-05 | 177 | 158 | 9 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 2.01e-05 | 177 | 158 | 9 | IPR003591 | |
| Domain | PTB/PI_dom | 2.38e-05 | 41 | 158 | 5 | IPR006020 | |
| Domain | Atrophin-like | 7.11e-05 | 2 | 158 | 2 | IPR002951 | |
| Domain | ANKS1 | 7.11e-05 | 2 | 158 | 2 | IPR033635 | |
| Domain | Atrophin-1 | 7.11e-05 | 2 | 158 | 2 | PF03154 | |
| Domain | PID | 8.62e-05 | 28 | 158 | 4 | PF00640 | |
| Domain | - | MXRA5 RTN4R LRRC72 CHADL DCN NOD2 TSKU LRRC3 AMIGO3 LRRC53 PHLPP2 | 9.30e-05 | 321 | 158 | 11 | 3.80.10.10 |
| Domain | L_dom-like | MXRA5 RTN4R LRRC72 CHADL DCN NOD2 TSKU LRRC3 AMIGO3 LRRC53 PHLPP2 | 1.13e-04 | 328 | 158 | 11 | IPR032675 |
| Domain | ZIP | 2.02e-04 | 14 | 158 | 3 | IPR003689 | |
| Domain | Zip | 2.02e-04 | 14 | 158 | 3 | PF02535 | |
| Domain | PTB | 3.55e-04 | 40 | 158 | 4 | SM00462 | |
| Domain | AMOP | 4.22e-04 | 4 | 158 | 2 | SM00723 | |
| Domain | AMOP | 4.22e-04 | 4 | 158 | 2 | PF03782 | |
| Domain | AMOP_dom | 4.22e-04 | 4 | 158 | 2 | IPR005533 | |
| Domain | AMOP | 4.22e-04 | 4 | 158 | 2 | PS50856 | |
| Domain | Znf_U1 | 1.85e-03 | 29 | 158 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 1.85e-03 | 29 | 158 | 3 | SM00451 | |
| Domain | S1 | 1.93e-03 | 8 | 158 | 2 | PF00575 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF133 ZNF311 ZNF777 ZNF775 ZNF266 HDAC5 ZNF189 POU4F2 PPARA ZNF226 ZNF227 TFAP2B ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 INTS5 ZNF320 ZNF665 EHMT1 ZNF770 ZFHX3 ZNF420 ZNF160 ZNF471 ZNF697 | 1.50e-06 | 1387 | 103 | 27 | M734 |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF775 HDAC5 ZNF189 POU4F2 PPARA ZNF226 TFAP2B ZNF786 ZNF250 ZNF610 ZNF665 EHMT1 ZNF814 ZNF770 ZFHX3 ZNF420 ZNF160 | 3.83e-05 | 768 | 103 | 17 | MM14851 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ZNF775 HDAC5 ZNF189 POU4F2 PPARA ZNF226 TFAP2B ZNF786 GTF3C4 ZNF250 ZNF610 INTS5 ZNF665 EHMT1 ZNF814 ZNF770 ZFHX3 ZNF420 ZNF160 | 1.35e-04 | 1022 | 103 | 19 | MM15436 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.31e-04 | 76 | 103 | 5 | M27219 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ABCB7 UBAP2 ATN1 ZNF329 IQSEC2 ZNF189 PEX12 IRS1 ZNF362 ZNF227 ERGIC2 SLC39A10 ZNF467 JMJD1C GTF3C4 ZNF250 INTS5 ZNF320 ZNF420 RERE ZNF160 ZNF574 ZNF697 ZNF646 | 1.82e-09 | 1203 | 161 | 24 | 29180619 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 SPRY2 KIAA0319L FBRSL1 TOR4A IRS1 ANKLE1 SFI1 PPARA SRCAP ITPR3 NOD2 MYOF INTS5 SH3TC1 IER5L TTLL4 EHMT1 PDCD11 COBL IL17RD | 4.72e-08 | 1105 | 161 | 21 | 35748872 |
| Pubmed | ZNF311 ZNF227 ZNF229 ZNF250 ZNF776 ZNF320 EHMT1 ZNF160 ZNF697 | 1.86e-07 | 181 | 161 | 9 | 37372979 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CACNA1C ZNF133 VEZT ZNF189 FBRSL1 WDR27 ZNF362 PPARA ATP10A JMJD1C DNAH1 USF3 SHC2 SH3TC1 SYNJ2 EHMT1 ZFHX2 COBL ZFHX3 RERE ERMARD MMP16 ANKS1A | 4.17e-07 | 1489 | 161 | 23 | 28611215 |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 3.23e-06 | 49 | 161 | 5 | 9630514 | |
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 12659941 | ||
| Pubmed | UBAP2 FBRSL1 SFI1 ANKRD50 INTS5 AMIGO3 SYNJ2 TTLL4 EHMT1 PDCD11 ANKS1A ZNF646 | 7.26e-06 | 529 | 161 | 12 | 14621295 | |
| Pubmed | 8.88e-06 | 60 | 161 | 5 | 18023262 | ||
| Pubmed | 1.22e-05 | 64 | 161 | 5 | 22261194 | ||
| Pubmed | Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo. | 2.13e-05 | 2 | 161 | 2 | 21586340 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 10814707 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 7657672 | ||
| Pubmed | Dyslexia-associated kiaa0319-like protein interacts with axon guidance receptor nogo receptor 1. | 2.13e-05 | 2 | 161 | 2 | 20697954 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 19710929 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 36454509 | ||
| Pubmed | Genome-wide RNA polymerase stalling shapes the transcriptome during aging. | 2.13e-05 | 2 | 161 | 2 | 36658433 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 21768085 | ||
| Pubmed | Restricted diet delays accelerated ageing and genomic stress in DNA-repair-deficient mice. | 2.13e-05 | 2 | 161 | 2 | 27556946 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 31653834 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 22226732 | ||
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 24563277 | ||
| Pubmed | Transcription factor AP-2beta: a negative regulator of IRS-1 gene expression. | 2.13e-05 | 2 | 161 | 2 | 20097161 | |
| Pubmed | 2.13e-05 | 2 | 161 | 2 | 20882040 | ||
| Pubmed | Transcriptome analyses based on genetic screens for Pax3 myogenic targets in the mouse embryo. | 2.69e-05 | 13 | 161 | 3 | 21143873 | |
| Pubmed | 5.22e-05 | 16 | 161 | 3 | 17444492 | ||
| Pubmed | 6.31e-05 | 17 | 161 | 3 | 29078349 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 37962045 | ||
| Pubmed | A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors. | 6.37e-05 | 3 | 161 | 2 | 26264164 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 30149370 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 19131340 | ||
| Pubmed | RERE deficiency causes retinal and optic nerve atrophy through degeneration of retinal cells. | 6.37e-05 | 3 | 161 | 2 | 33742727 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 10498399 | ||
| Pubmed | Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. | 6.37e-05 | 3 | 161 | 2 | 21706003 | |
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 17875921 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 38123547 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 19289372 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 16979838 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 15759454 | ||
| Pubmed | 6.37e-05 | 3 | 161 | 2 | 28514298 | ||
| Pubmed | 1.05e-04 | 20 | 161 | 3 | 12743021 | ||
| Pubmed | HECW1 ZNF623 ATP10A JMJD1C SHROOM4 MYOF ZNF610 USF3 ZNF665 ZNF160 | 1.08e-04 | 493 | 161 | 10 | 15368895 | |
| Pubmed | IRF2BP2 HSPG2 UBAP2 HDAC5 ATN1 FBRSL1 SRCAP JMJD1C RBM20 MIDN EHMT1 PDCD11 CCAR2 ZNF770 ZFHX3 ZNF420 RERE ZNF471 | 1.18e-04 | 1429 | 161 | 18 | 35140242 | |
| Pubmed | 1.21e-04 | 103 | 161 | 5 | 10574462 | ||
| Pubmed | 1.22e-04 | 21 | 161 | 3 | 7865130 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 11960706 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 17299578 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 17932351 | ||
| Pubmed | Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. | 1.27e-04 | 4 | 161 | 2 | 12865926 | |
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 22880013 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 18204222 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 28351583 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 32557569 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 23300874 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 17150957 | ||
| Pubmed | 1.27e-04 | 4 | 161 | 2 | 15940190 | ||
| Pubmed | 1.33e-04 | 105 | 161 | 5 | 9628581 | ||
| Pubmed | Genome-wide association study identifies five new schizophrenia loci. | 1.61e-04 | 23 | 161 | 3 | 21926974 | |
| Pubmed | 1.83e-04 | 24 | 161 | 3 | 33722704 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 16985021 | ||
| Pubmed | Differential and restricted expression of novel collagen VI chains in mouse. | 2.11e-04 | 5 | 161 | 2 | 21477648 | |
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 20540670 | ||
| Pubmed | The expanded collagen VI family: new chains and new questions. | 2.11e-04 | 5 | 161 | 2 | 23869615 | |
| Pubmed | MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding. | 2.11e-04 | 5 | 161 | 2 | 29196321 | |
| Pubmed | Expression and localization of proteoglycans during limb myogenic activation. | 2.11e-04 | 5 | 161 | 2 | 11357198 | |
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 17313739 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 15746040 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 17438655 | ||
| Pubmed | 2.11e-04 | 5 | 161 | 2 | 19029193 | ||
| Pubmed | ZSWIM8 ATN1 VEZT VPS4A FBRSL1 EMILIN3 ZNF362 SRCAP ZNF610 SH3TC1 EHMT1 ZFHX3 RERE ZNF574 ZNF646 | 2.26e-04 | 1116 | 161 | 15 | 31753913 | |
| Pubmed | 2.40e-04 | 65 | 161 | 4 | 23453885 | ||
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 2.62e-04 | 27 | 161 | 3 | 14581517 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 3.00e-04 | 125 | 161 | 5 | 32891193 | |
| Pubmed | 3.16e-04 | 6 | 161 | 2 | 12122449 | ||
| Pubmed | 3.16e-04 | 6 | 161 | 2 | 15729686 | ||
| Pubmed | AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle. | 3.16e-04 | 6 | 161 | 2 | 9918694 | |
| Pubmed | Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. | 3.16e-04 | 6 | 161 | 2 | 16284373 | |
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 3.16e-04 | 6 | 161 | 2 | 21762810 | |
| Pubmed | 3.16e-04 | 6 | 161 | 2 | 20100865 | ||
| Pubmed | Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. | 3.16e-04 | 6 | 161 | 2 | 15849729 | |
| Pubmed | Genetic determinants of insulin action in polycystic ovary syndrome. | 3.16e-04 | 6 | 161 | 2 | 15926113 | |
| Pubmed | NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. | 3.16e-04 | 6 | 161 | 2 | 18026184 | |
| Pubmed | A lymphatic defect causes ocular hypertension and glaucoma in mice. | 3.16e-04 | 6 | 161 | 2 | 25202984 | |
| Pubmed | 3.16e-04 | 6 | 161 | 2 | 16352659 | ||
| Pubmed | 3.16e-04 | 6 | 161 | 2 | 25576668 | ||
| Pubmed | 3.16e-04 | 6 | 161 | 2 | 19434073 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | HELT POU3F4 POU4F2 PPARA TFAP2B HOXA4 USF3 ZFHX2 ZFHX3 RERE ZNF160 SIX2 FOXC2 | 3.30e-04 | 908 | 161 | 13 | 19274049 |
| Pubmed | ZNF775 PPARA SRCAP ZNF623 ZDHHC4 ZNF786 ZNF610 ZNF665 ZFHX3 ZNF160 ZNF697 ZNF646 | 4.05e-04 | 808 | 161 | 12 | 20412781 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | ZNF189 ZNF362 SRBD1 GTF3C4 INTS5 EHMT1 PDCD11 CCAR2 ZFHX3 ZNF646 | 4.11e-04 | 583 | 161 | 10 | 29844126 |
| Pubmed | Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. | 4.40e-04 | 7 | 161 | 2 | 16481466 | |
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 4.40e-04 | 7 | 161 | 2 | 22510986 | |
| Pubmed | 4.40e-04 | 7 | 161 | 2 | 20622121 | ||
| Pubmed | Three novel collagen VI chains with high homology to the alpha3 chain. | 4.40e-04 | 7 | 161 | 2 | 18276594 | |
| Pubmed | Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. | 4.40e-04 | 7 | 161 | 2 | 16537713 | |
| Pubmed | Modulation of nucleotide excision repair in human lymphocytes by genetic and dietary factors. | 4.40e-04 | 7 | 161 | 2 | 19878615 | |
| Pubmed | Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). | 4.40e-04 | 7 | 161 | 2 | 18400749 | |
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 5.53e-04 | 303 | 161 | 7 | 25056061 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ZNF362 ZNF226 SRBD1 SRCAP JMJD1C GTF3C4 ZNF776 EHMT1 ZNF770 TRMT61A | 5.69e-04 | 608 | 161 | 10 | 36089195 |
| Pubmed | 5.72e-04 | 35 | 161 | 3 | 22688191 | ||
| Pubmed | Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. | 5.86e-04 | 8 | 161 | 2 | 19270000 | |
| Pubmed | 5.86e-04 | 8 | 161 | 2 | 20660057 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ERCC1 ZNF329 ZNF880 ZNF226 ZNF227 ZNF229 SHISA7 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 CLEC11A SIGLEC10 ZNF814 ZNF534 ZNF420 ZNF160 ZNF471 ZNF574 LILRB4 | 1.49e-09 | 1192 | 161 | 21 | chr19q13 |
| Cytoband | 19q13.43 | 1.46e-05 | 87 | 161 | 5 | 19q13.43 | |
| Cytoband | 7q36.1 | 1.38e-04 | 74 | 161 | 4 | 7q36.1 | |
| Cytoband | 19q13.41 | 1.70e-04 | 78 | 161 | 4 | 19q13.41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 1.06e-03 | 325 | 161 | 6 | chr9q34 | |
| Cytoband | 1p36.23 | 1.08e-03 | 14 | 161 | 2 | 1p36.23 | |
| Cytoband | 2p21 | 1.31e-03 | 61 | 161 | 3 | 2p21 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF133 ZNF311 ZNF777 ZNF775 ZNF266 ZNF329 ZNF189 ZNF880 ZNF362 ZNF226 ZNF227 ZNF229 ZNF467 ZNF623 ZNF774 ZNF786 ZNF250 ZNF610 ZNF776 ZNF320 ZNF497 ZNF665 ZFHX2 ZNF814 ZNF534 ZNF770 ZFHX3 ZNF420 ZFP92 ZNF160 ZNF471 ZSCAN23 ZNF574 ZNF697 ZNF646 | 2.84e-21 | 718 | 119 | 35 | 28 |
| GeneFamily | WD repeat domain containing|ERCC excision repair associated | 8.83e-04 | 7 | 119 | 2 | 1268 | |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 LAMB4 MXRA5 COL6A6 EMILIN3 COL6A5 CHADL DCN HAPLN1 TSKU | 7.42e-06 | 275 | 159 | 10 | M5884 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.83e-07 | 186 | 160 | 8 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.39e-07 | 133 | 160 | 7 | 29b0c2c682c6b97823e7d8d8ba1f5114044b30ba | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.22e-06 | 181 | 160 | 7 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.37e-06 | 182 | 160 | 7 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.37e-06 | 182 | 160 | 7 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.37e-06 | 182 | 160 | 7 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 4.53e-06 | 183 | 160 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.53e-06 | 183 | 160 | 7 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 185 | 160 | 7 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 5.41e-06 | 188 | 160 | 7 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.00e-06 | 191 | 160 | 7 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.00e-06 | 191 | 160 | 7 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.21e-06 | 192 | 160 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 192 | 160 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.43e-06 | 193 | 160 | 7 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.65e-06 | 194 | 160 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-06 | 196 | 160 | 7 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-06 | 196 | 160 | 7 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.11e-06 | 196 | 160 | 7 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.59e-06 | 198 | 160 | 7 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.59e-06 | 198 | 160 | 7 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.11e-06 | 200 | 160 | 7 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.11e-06 | 200 | 160 | 7 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.11e-06 | 200 | 160 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-05 | 143 | 160 | 6 | b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7 | |
| ToppCell | Mild/Remission-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.42e-05 | 145 | 160 | 6 | 7827aef87f834cd0d19780417757c9386e19b22e | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.23e-05 | 157 | 160 | 6 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | Healthy/Control-CD8+_T_naive|World / Disease group and Cell class | 2.31e-05 | 158 | 160 | 6 | 70680b29428b6bf882b1fae36f924b775961176b | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.40e-05 | 159 | 160 | 6 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | Healthy/Control-CD8+_T_naive|Healthy/Control / Disease group and Cell class | 2.48e-05 | 160 | 160 | 6 | e1386c21fcbbf57fa32d8bdfba3cb1887477ff73 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-05 | 161 | 160 | 6 | 8aaca49b53a551395f4025ac4e535c7b0ce41a49 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-05 | 161 | 160 | 6 | deb10628d258fb813c293f81fb71be8e383dc82a | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 3.16e-05 | 167 | 160 | 6 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 3.27e-05 | 168 | 160 | 6 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.38e-05 | 169 | 160 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 3.38e-05 | 169 | 160 | 6 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 3.61e-05 | 171 | 160 | 6 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.85e-05 | 173 | 160 | 6 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 173 | 160 | 6 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-05 | 174 | 160 | 6 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-05 | 176 | 160 | 6 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-05 | 176 | 160 | 6 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.24e-05 | 176 | 160 | 6 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.24e-05 | 176 | 160 | 6 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 177 | 160 | 6 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.37e-05 | 177 | 160 | 6 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 178 | 160 | 6 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 178 | 160 | 6 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.51e-05 | 178 | 160 | 6 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.66e-05 | 179 | 160 | 6 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.80e-05 | 180 | 160 | 6 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.11e-05 | 182 | 160 | 6 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 6.11e-05 | 188 | 160 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Endothelial-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.11e-05 | 188 | 160 | 6 | ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.11e-05 | 188 | 160 | 6 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 189 | 160 | 6 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 189 | 160 | 6 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 189 | 160 | 6 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-05 | 189 | 160 | 6 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 189 | 160 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.48e-05 | 190 | 160 | 6 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.67e-05 | 191 | 160 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.67e-05 | 191 | 160 | 6 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.87e-05 | 192 | 160 | 6 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.87e-05 | 192 | 160 | 6 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.87e-05 | 192 | 160 | 6 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.07e-05 | 193 | 160 | 6 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.27e-05 | 194 | 160 | 6 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-05 | 194 | 160 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LAM-Mesenchyme-Mesenchyme|LAM / Condition, Lineage and Cell class | 7.69e-05 | 196 | 160 | 6 | 4590fb157797a68dca4295e203702bbae279cd03 | |
| ToppCell | LAM-Mesenchyme|LAM / Condition, Lineage and Cell class | 7.69e-05 | 196 | 160 | 6 | e7918b0cd5eeb675012f871f43f4388471845035 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.91e-05 | 197 | 160 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.91e-05 | 197 | 160 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.91e-05 | 197 | 160 | 6 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.23e-05 | 123 | 160 | 5 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.36e-05 | 199 | 160 | 6 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.36e-05 | 199 | 160 | 6 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.36e-05 | 199 | 160 | 6 | a272c54baf8de59c0f259e6498d144a0de8d8924 | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 8.36e-05 | 199 | 160 | 6 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.36e-05 | 199 | 160 | 6 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Transverse-T_cell-Tfh|T_cell / Region, Cell class and subclass | 8.36e-05 | 199 | 160 | 6 | 33ffea12b8228e0b5bd8942531c3b21d24224725 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 8.36e-05 | 199 | 160 | 6 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.36e-05 | 199 | 160 | 6 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.36e-05 | 199 | 160 | 6 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.36e-05 | 199 | 160 | 6 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.60e-05 | 200 | 160 | 6 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Mesenchymal|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | e5b7d9622b96bb20c81ac76b4e60e8b44fa9cca1 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | 69707f9576d326a06faac49701ef5cd632e760f6 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.60e-05 | 200 | 160 | 6 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial-Proteoglycan-expressing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | f94381d0a3b5b81cdbb13b75fc0e4910cbd70382 | |
| ToppCell | severe-cDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.60e-05 | 200 | 160 | 6 | 26e04ea276dbca5cde48335c401269c7123b54d2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.60e-05 | 200 | 160 | 6 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 8.60e-05 | 200 | 160 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.11e-04 | 131 | 160 | 5 | 308ddb7fe113eac5dbeb9cb0b688d9e09275ce5e | |
| Drug | Mesalamine [89-57-6]; Up 200; 26.2uM; MCF7; HT_HG-U133A | HSPG2 SPRY2 ZNF362 DCN HAPLN1 MYOF SLC22A14 CLEC11A NYNRIN RERE SIX2 | 1.72e-07 | 199 | 160 | 11 | 7241_UP |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.02e-05 | 195 | 160 | 9 | 1539_UP | |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 1.15e-05 | 198 | 160 | 9 | 3402_DN | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.15e-05 | 198 | 160 | 9 | 2636_UP | |
| Disease | dentatorubral-pallidoluysian atrophy (implicated_via_orthology) | 2.71e-05 | 2 | 154 | 2 | DOID:0060162 (implicated_via_orthology) | |
| Disease | Pena Shokeir syndrome Type 2 | 8.09e-05 | 3 | 154 | 2 | C2931277 | |
| Disease | CAMFAK syndrome | 8.09e-05 | 3 | 154 | 2 | C1859312 | |
| Disease | angiopoietin-1 receptor measurement | 1.27e-04 | 19 | 154 | 3 | EFO_0010600 | |
| Disease | Cerebrooculofacioskeletal Syndrome 1 | 1.61e-04 | 4 | 154 | 2 | C0220722 | |
| Disease | larynx cancer (is_implicated_in) | 4.00e-04 | 6 | 154 | 2 | DOID:2596 (is_implicated_in) | |
| Disease | Xeroderma pigmentosum | 9.51e-04 | 9 | 154 | 2 | cv:C0043346 | |
| Disease | renal Wilms' tumor (is_implicated_in) | 1.18e-03 | 10 | 154 | 2 | DOID:5176 (is_implicated_in) | |
| Disease | Reactive hypoglycemia | 1.18e-03 | 10 | 154 | 2 | C0271710 | |
| Disease | Fasting Hypoglycemia | 1.18e-03 | 10 | 154 | 2 | C0271708 | |
| Disease | response to anticoagulant | 1.28e-03 | 41 | 154 | 3 | GO_0061476 | |
| Disease | Craniofacial Abnormalities | 1.39e-03 | 156 | 154 | 5 | C0376634 | |
| Disease | Hypoglycemia | 1.44e-03 | 11 | 154 | 2 | C0020615 | |
| Disease | schizophrenia, anorexia nervosa | 2.03e-03 | 48 | 154 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 2.36e-03 | 14 | 154 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | response to olanzapine | 2.72e-03 | 15 | 154 | 2 | GO_0097333 | |
| Disease | Cardiovascular Abnormalities | 3.10e-03 | 16 | 154 | 2 | C0243050 | |
| Disease | Lipidemias | 3.50e-03 | 17 | 154 | 2 | C1706412 | |
| Disease | Limb Deformities, Congenital | 3.50e-03 | 17 | 154 | 2 | C0206762 | |
| Disease | Hyperlipidemia | 3.50e-03 | 17 | 154 | 2 | C0020473 | |
| Disease | ulcerative colitis, Crohn's disease | 4.83e-03 | 20 | 154 | 2 | EFO_0000384, EFO_0000729 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HTLHLSHLNRFPARG | 171 | Q8N163 | |
| PGALLRAEFHQHQHT | 431 | Q9HCM7 | |
| EALGHHGRSRKQPHQ | 501 | Q8NAG6 | |
| PRGHAHLAALVNHES | 196 | Q96RQ1 | |
| GRHHILSAGPHALTQ | 336 | Q99678 | |
| HPLHENEVLRHQLFA | 1106 | P54259 | |
| KRAHQLPGHLTQEHD | 96 | Q9BSQ5 | |
| AHGHTPLTLAARQGH | 576 | Q9ULJ7 | |
| HTPLHLAARNGHKAV | 216 | Q92625 | |
| VCLATGPRLHHNQTH | 351 | Q86WK7 | |
| ELELHLHLHQPRAQQ | 911 | Q9P1Z9 | |
| NPLLHLSNLTHDILH | 2196 | Q9Y485 | |
| ARHQEHLLAHLSPEL | 551 | O60312 | |
| RPDVLLHSAHHGLDA | 146 | Q92481 | |
| GDTLLEHDHLHLLPN | 76 | Q8TDY8 | |
| IQRHPINQGNLIHSH | 941 | Q6ZS30 | |
| AHELNDFHGVAPLHL | 396 | Q5T481 | |
| HQTHGSLLRLHQVTP | 2196 | P98160 | |
| PARHQTHGSQLRLHL | 2966 | P98160 | |
| PVLQHFVHLLATHGR | 1281 | Q14573 | |
| LIHHGPSHSRVNEQN | 111 | Q7Z6G8 | |
| LLHASHTGQEPSERH | 1226 | Q7Z6G8 | |
| AHQIALQQHCLAPPH | 256 | P46095 | |
| NLIGHAHPNALNLHT | 221 | A6NFD8 | |
| LHSRDHGLQEPGQHT | 511 | Q8NFM7 | |
| IAHRHLIPKQLEQHG | 521 | Q86WA8 | |
| AHPLLHLRSEHGAQQ | 161 | Q8NHJ6 | |
| AAGEVLNHSDHHPIL | 736 | Q8IZA0 | |
| GRLPNHLTHRQHLQR | 1056 | Q76N89 | |
| KEDNGLHPHRQRHFI | 511 | A6NM62 | |
| ISHLPDGAFQHLHRL | 76 | Q9BY71 | |
| QCHLHHENPALGRER | 156 | Q5JU85 | |
| LLQHQSPHLLGQAHP | 836 | Q15652 | |
| HNLHPDYIHGRLQSL | 146 | P07992 | |
| LLPRTHLQAELHQHG | 146 | Q6H9L7 | |
| GEVPDSLLHHRHSQH | 271 | A6NFC9 | |
| LLTHHFGRNIPQHVH | 261 | Q96RD2 | |
| HRGHDHVLQFLVSIP | 736 | O60437 | |
| DNGSLANTPHLRELH | 261 | P07585 | |
| NSLGGLASVNHLHLH | 206 | Q6ZNW5 | |
| LNHSGDLNHLPGHTF | 426 | Q99958 | |
| HELTFPNRLGHSHLS | 101 | P05162 | |
| LQLHNRAKGHHDGAA | 111 | P35568 | |
| EDLQLGAIIHHRSPH | 86 | P49335 | |
| LGDQLEGHSRNHLKH | 81 | Q5T2D3 | |
| HILEAPQHGLERRHL | 151 | Q9NVK5 | |
| RHLDHQHPQTIEQGH | 221 | Q9P2D7 | |
| HFDLHPGSAQLRAHG | 46 | P02008 | |
| GTNHEHDQPAHLTLR | 526 | Q16134 | |
| HLVHHQALAVAGLSP | 2006 | Q13936 | |
| ELASHPLDHHLVQLG | 2456 | A8TX70 | |
| ELCLQNHLNPSHHAL | 91 | O75128 | |
| EHHHLRPPNRNDFLN | 41 | P0DN25 | |
| EHAEATHRRALPNHL | 136 | Q02410 | |
| SQPLQGESHAHSHVL | 691 | A4D0S4 | |
| NHVSPAHRQALRGHS | 151 | Q8NAJ2 | |
| HHVGHQLGSDVQLLA | 266 | A6NC97 | |
| NHQEGPRIRDHLSHG | 361 | Q5T6L9 | |
| PRIRDHLSHGEINLH | 366 | Q5T6L9 | |
| KVHGLALGHEAHLQR | 271 | Q9NT22 | |
| SHLVPQNGHQATHLE | 436 | Q9H4B8 | |
| GSPHGHASLLQHVLL | 436 | Q9UQL6 | |
| AFQGVPHLTHLDLRH | 81 | Q6NUI6 | |
| ASRNLNQHEVAGHPH | 16 | Q9Y267 | |
| LLHLLPHSQGGHDHS | 456 | Q9ULF5 | |
| LLQVLSAGDHPPHNH | 46 | Q504Y0 | |
| KLHLQNIHLHEPNRG | 931 | Q8IZU8 | |
| DLHAVNIHGDSPLHI | 931 | Q9H9B1 | |
| PAHGLHASHVLQPQL | 126 | Q00056 | |
| RDTLLALHQHGHSGP | 306 | Q7Z5L9 | |
| EAPREHLDHQAAHQP | 66 | B1AKI9 | |
| EAREPAARHQLHQLH | 101 | Q5T953 | |
| DLASHPLDHHLVQLG | 2131 | A6NMZ7 | |
| PSLHILLLHHNELTN | 111 | A6NJI9 | |
| LTAILHQEHSGRKHP | 1171 | Q9P2P1 | |
| HDRAIHIQAENGPHL | 26 | P10915 | |
| HVLRLHLQSNHPDDI | 406 | Q07869 | |
| LAAQHAPLQHRHVLA | 156 | Q504T8 | |
| RLLLHQNRVAHVHPH | 206 | Q9BZR6 | |
| RNLAHQQHGVTLLHR | 406 | A8K8P3 | |
| QPGLQVGSHHLRLHR | 261 | O15056 | |
| SQHLHSPQHKLSERG | 566 | Q6T4R5 | |
| AHQHSGALHQSLTPL | 71 | Q6ZSG1 | |
| AFLSGHILHHEPAIQ | 951 | Q8TC59 | |
| FQHLLHTLNLPGHGL | 121 | P29622 | |
| HHQPHQALEGELLEH | 181 | Q12837 | |
| QSFRHAHPLTGHIVN | 296 | Q99527 | |
| HGNSIENPHLLTLFH | 46 | P28715 | |
| TGHRHSAPEQLLASH | 406 | Q9ULL8 | |
| SAPEQLLASHLQHVH | 411 | Q9ULL8 | |
| GHHLPQHLRTASKNE | 521 | A6NL88 | |
| HRLAALQHRLGHGEL | 1196 | Q8TE82 | |
| LHLHQQDPLHQGSAG | 1436 | Q9P2R6 | |
| GGPHLAVLHSVLHRN | 981 | Q6P9B9 | |
| GQHHLISQPAHVALI | 1246 | Q6ZRS2 | |
| AQHHSPLLRLAGVQL | 186 | O00623 | |
| IHHHQILAINRGENL | 431 | Q8N5C6 | |
| QHKHERLHGLPEHRQ | 76 | O43597 | |
| ALLHLLPHAQEGRHA | 261 | Q6ZMH5 | |
| LHLHNLDLGFHLSRQ | 231 | O75027 | |
| ERGTHHGLLANPHSI | 686 | O75027 | |
| AGLDAGLHQLHVRLH | 116 | Q9Y240 | |
| NPVHLEAQGIHISRH | 181 | Q96LP6 | |
| HGNNLNSLHQLIHPE | 251 | Q8IUQ0 | |
| SHLANHRRIHTGEKP | 611 | Q9H7R5 | |
| PHLSRHRKIHAGENS | 441 | Q8N9Z0 | |
| TSHLSDHVANGPLLH | 666 | Q14690 | |
| QLIHHQRSHSGERPF | 306 | A6NM28 | |
| NLTRHQRIHTGDKPH | 386 | O75820 | |
| SQLLHHHLPQDAQSG | 1076 | Q5T6F2 | |
| LTPRTHGRINHVFNH | 241 | Q5GJ75 | |
| SNLANHHRIHTGEKP | 561 | Q6PDB4 | |
| LAEHLKIHAGARPHA | 261 | Q6ZNH5 | |
| AHLANHRRIHTGEKP | 746 | Q9HCG1 | |
| SHLIQHQRIHTGERP | 296 | P15622 | |
| NSPSHLIRHQRIHTG | 451 | A2RRD8 | |
| LPGQHHIELQGDLLH | 121 | Q7RTX1 | |
| EQLVGRPALHFHLSH | 1016 | Q9C0A1 | |
| HELGHALGLEHSNDP | 246 | P51512 | |
| HSLHPARDLQSHRPA | 126 | Q9HC29 | |
| VGHLHLRILHLANNQ | 641 | Q6ZVD8 | |
| ISHLIDHHLQNGQPI | 551 | P98077 | |
| SLLLHLLGQALVHHP | 391 | Q8NE28 | |
| SHFITHQRIHLGDRP | 416 | Q6NX45 | |
| PHQLQQHLRSHREGV | 321 | Q6ZN55 | |
| EPQVHRNIHSHGLRS | 311 | Q9NPG8 | |
| APTGHLHTVEFHQQR | 126 | Q96FX7 | |
| QKPNLARHQRHHTGE | 146 | Q96BV0 | |
| ASHLQAHARGHSQVP | 1601 | O15015 | |
| SHLARHRNIHTGEKP | 576 | Q76KX8 | |
| LQQHVPAQGVSHLHS | 1441 | Q68DE3 | |
| SNRPAHNISHILGHD | 2226 | Q68DE3 | |
| HHPNIINLLGACEHR | 881 | Q02763 | |
| LHALAHDVGHLGPLS | 71 | Q5BKY6 | |
| LNVHNSHVTGLHSLP | 411 | Q9UKN8 | |
| DPLQHHHGLQDSILN | 266 | Q9NPC8 | |
| QLVHLERHQLTHSLP | 66 | Q6IQ21 | |
| GLRHSAHLNRHQRVP | 301 | Q9UJW7 | |
| SHLANHQRIHTGEKP | 366 | Q5TEC3 | |
| SHLQDHQRLHTGEKP | 376 | Q9NYT6 | |
| SHLNRHQNIHSGEKP | 451 | P52736 | |
| LDELHGFLQPQRSHH | 276 | Q9NXH8 | |
| LLQVHQHAHGGERPF | 411 | Q8N393 | |
| LLSHQGLHTGERPFH | 691 | Q8N393 | |
| QRLSPAHAHNHLRAP | 1741 | A7E2V4 | |
| PHRHHLHTVQGLASL | 276 | Q969Z4 | |
| QPAHLAQHQRIHTGE | 301 | Q9BX82 | |
| SHLQQHTRIHTGDRP | 296 | Q5T0B9 | |
| LNLRHHQRVHTGEKP | 701 | Q86WZ6 | |
| SHLSQHQRLHTGEKP | 516 | Q8TAQ5 | |
| SHQLLILRGHHQPIT | 61 | A2RRH5 | |
| HRILSDVTQGLPHAH | 371 | Q9HBM0 | |
| AHLTEHQKIHSGDRP | 416 | O75123 | |
| RILALNHHTAGHPSE | 676 | P0DP72 | |
| HHLLEHQRAHTGERP | 791 | Q9ULD5 | |
| HARHPLGSQHVSLSL | 426 | Q96LC7 | |
| HVDLSHNLIHRLVPH | 161 | Q8WUA8 | |
| IHLLASHASGLNHNP | 421 | Q14679 | |
| SHLAVHQRLHSREGP | 496 | Q86UD4 | |
| HQLIHGEAAHAAPDA | 561 | Q7Z7K2 | |
| SHLLVHQRIHNGEKP | 701 | B7Z6K7 | |
| GISLNLRHLALHPHT | 701 | O43156 | |
| NLTNHRRIHTGEKPH | 541 | Q5JNZ3 | |
| HLQLHLTHLHSVAPD | 1266 | Q15911 | |
| AIQNHVNHHSLRTLP | 2581 | Q9P2D8 | |
| HLGSTPHNLTDANIH | 306 | Q9UN37 | |
| QNAGLFHHLRIHTGE | 316 | Q3MJ62 | |
| SLIQHQQIHSGERPH | 446 | Q68DI1 | |
| INHSHLQGHLRTHNG | 166 | Q14584 | |
| LHLEGNLLHQLHPST | 156 | Q9NR99 | |
| LHQHLGAPEERLALH | 1716 | Q9NZM1 |